IQVIA Overview
- Status
-
Public
- Employees
-
83,000
- Stock Symbol
-
IQV
- Investments
-
110
- Share Price
-
$238.82
- (As of Thursday Closing)
IQVIA General Information
Description
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The Technology & Analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Contact Information
Website
www.iqvia.com
Formerly Known As
IMS Health, Quintiles IMS, IMS Consulting Group
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Other Healthcare Services
Other Industries
Other Healthcare Technology Systems
IT Consulting and Outsourcing
Stock Exchange
NYS
Primary Office
- 83 Wooster Heights Road
- Danbury, CT 06810
- United States
+1 (203) 000-0000
IQVIA Stock Performance
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $238.82 | $240.62 | $194.67 - $285.61 | $44.9B | 187M | 1.02M | $6.10 |
IQVIA Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 52,525,658 | 64,820,885 | 45,795,508 | 41,258,745 |
| Revenue | 14,136,000 | 13,874,000 | 11,359,000 | 11,088,000 |
| EBITDA | 2,855,000 | 2,761,000 | 2,070,000 | 1,992,000 |
| Net Income | 1,160,000 | 966,000 | 279,000 | 191,000 |
| Total Assets | 24,413,000 | 24,689,000 | 24,564,000 | 23,251,000 |
| Total Debt | 13,052,000 | 12,438,000 | 12,904,000 | 12,041,000 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
IQVIA Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
IQVIA Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a
Other Healthcare Services
Danbury, CT
83,000
As of 2022
00000
000000000
00000
000000
usmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exer
0000000000000
Morrisville, NC
00000
As of 0000
00000
00000000000
00000
000000
laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptat
00000 0000000000 0000000000 0000000
Blue Bell, PA
0000
As of 0000
00.00
00000000000
00.00
Add Comparison
IQVIA Competitors (12)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Syneos Health | Corporation | Morrisville, NC | 00000 | 00000 | 00000000000 | 00000 |
| 0000000 000000 | Private Equity-Backed | Blue Bell, PA | 0000 | 00.00 | 00000000000 | 00.00 |
| 00000 0000000 | Corporation | Dickinson, ND | 00 | 000000000 - | ||
| 0000000 | Formerly PE-Backed | Bethesda, MD | 000 | 000000000000 | ||
| 00 0000000000 | Corporation | Evanston, IL | 00000 |
IQVIA Patents
IQVIA Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4009194-A1 | Automated classification and interpretation of life science documents | Pending | 04-Dec-2020 | 000000000 | 0 |
| US-20220164535-A1 | Classification code parser | Pending | 25-Nov-2020 | 0000000000 | |
| EP-3796333-A1 | Unbiased etl system for timed medical event prediction | Pending | 20-Sep-2019 | 000000000 | 0 |
| US-20210090745-A1 | Unbiased etl system for timed medical event prediction | Pending | 20-Sep-2019 | 000000000 | |
| US-20200410614-A1 | Machine learning techniques for automatic evaluation of clinical trial data | Pending | 25-Jun-2019 | G16H10/60 |
IQVIA Executive Team (88)
IQVIA Board Members (20)
| Name | Representing | Role | Since |
|---|---|---|---|
| 000 0000000 | IQVIA | Chief Executive Officer & Chairman | 000 0000 |
| 00000 0000 | Self | Board Member | 000 0000 |
| 0000000 0000000 | Self | Board Member | 000 0000 |
| 00000 000000 | Self | Board Member | 000 0000 |
| 0000 00000000000 | Bain Capital | Board Member | 000 0000 |
IQVIA Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
IQVIA Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
IQVIA Investments & Acquisitions (110)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000000 | 01-Jul-2022 | 0000000000 | IT Consulting and Outsourcing | ||
| 000000 | 26-Oct-2021 | 0000000000 | Enterprise Systems (Healthcare) | ||
| 000 000000000 | 01-Aug-2021 | 0000000000 | Media and Information Services (B2B) | ||
| 00000000, 000 | 01-Jul-2021 | 0000000000 | 00.000 | Other Healthcare Services | |
| Q2 Solutions | 01-Apr-2021 | Secondary Transaction - Private | 00000 | Laboratory Services (Healthcare) |
IQVIA Subsidiaries (40)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Quality Health (UK) | Other Healthcare Services | Chesterfield, United Kingdom | 2016 |
| 000000000 00000000 | Biotechnology | Marietta, GA | 0000 |
| 00000 000 | Biotechnology | Durham, NC | 0000 |
| 000 00000000000000 | Media and Information Services (B2B) | Hawthorne, NY | 0000 |
| 00 000000000 | Laboratory Services (Healthcare) | Durham, NC | 0000 |